M33 Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.